SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-128829
Filing Date
2018-04-24
Accepted
2018-04-24 16:20:55
Documents
3
Period of Report
2018-04-24
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d565308d8k.htm 8-K 14698
2 EX99.1 d565308dex991.htm EX-99.1 24526
3 GRAPHIC g565308g34b68.jpg GRAPHIC 8777
  Complete submission text file 0001193125-18-128829.txt   52587
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35921 | Film No.: 18771653
SIC: 2834 Pharmaceutical Preparations